TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29135656

Group type: EXPERIMENTAL
Intervention: 3-monthly creatinine clearance (CrCl) monitoring
Number of subjects: 5358

Group type: COMPARATOR
Intervention: 6-monthly creatinine clearance (CrCl) monitoring
Number of subjects: 5358
Study: 27154160

Group type: EXPERIMENTAL
Intervention: Radial artery (RA) grafts
Number of subjects: 234

Group type: COMPARATOR
Intervention: Saphenous vein grafts (SVGs)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Patients with significant graft stenosis
Number of subjects: 234

Group type: COMPARATOR
Intervention: Patients without significant graft stenosis
Number of subjects: 234
Study: 24251386

Group type: EXPERIMENTAL
Intervention: Partial removable dental prostheses (RDP)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Functionally orientated treatment based on the shortened dental arch concept (SDA)
Number of subjects: 92

Group type: COMPARATOR
Intervention: SDA
Number of subjects: 92
Study: 22377834

Group type: EXPERIMENTAL
Intervention: Text based intervention
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Video based intervention
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 863

Group type: COMPARATOR
Intervention: Mismatched group (participants who preferred a different mode)
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Matched group (participants who preferred their assigned mode)
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: All groups (matched and mismatched)
Number of subjects: 863

Group type: COMPARATOR
Intervention: Mismatched group
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Matched group
Number of subjects: 863
Study: 20869107

Group type: EXPERIMENTAL
Intervention: Double-layer urethrovesical (UV) anastomosis
Number of subjects: 116

Group type: COMPARATOR
Intervention: Single-layer urethrovesical (UV) anastomosis
Number of subjects: 116
Study: 18711405

Group type: EXPERIMENTAL
Intervention: CABG with intramuscular or intracoronary administration of BMCs
Number of subjects: 63

Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 63
Study: 15866056

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Regular insulin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nondiabetic control (no insulin)
Number of subjects: 40
Study: 12067326

Group type: EXPERIMENTAL
Intervention: Electrophysiological examination
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Hyperexcitability index (HI)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Amino acids acting as neurotransmitters
Number of subjects: 31
Study: 9708578

Group type: EXPERIMENTAL
Intervention: Interdisciplinary rounds
Number of subjects: 1102

Group type: COMPARATOR
Intervention: Traditional rounds
Number of subjects: 1102
Study: 8544207

Group type: EXPERIMENTAL
Intervention: Hubcrank propulsion mechanism
Number of subjects: 10

Group type: COMPARATOR
Intervention: Handrim propulsion mechanism
Number of subjects: 10
Study: 2223423

Group type: EXPERIMENTAL
Intervention: CsA and prednisolone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: CsA and azathioprine and prednisolone
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: CsA concentrations
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: CsA concentrations measured by polyclonal r.i.a.
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: CsA concentrations measured by specific monoclonal r.i.a.
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: CsA concentrations measured by h.p.l.c.
Number of subjects: 66
Study: 396214

Group type: EXPERIMENTAL
Intervention: suxibuzon
Number of subjects: 30

Group type: COMPARATOR
Intervention: indomethacin
Number of subjects: 30
Study: 31957070

Group type: EXPERIMENTAL
Intervention: 2 g amoxicillin pre-operative and 500 mg thrice daily on days 1-3 post-operative
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 30824647

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg once every 2 weeks
Number of subjects: 317

Group type: COMPARATOR
Intervention: Tofacitinib and Adalimumab
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Baseline CRP levels > 2.87 mg/l
Number of subjects: 317
Study: 28067745

Group type: EXPERIMENTAL
Intervention: Trospium chloride XR 60 mg daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 26124478

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study: 23042474

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Education Control (EC)
Number of subjects: 216
Study: 22185811

Group type: EXPERIMENTAL
Intervention: mpHBV (10 µg HBsAg)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: RECOMBIVAX HB™ (10 µg HBsAg)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: ENGERIX‐B™ (20 µg HBsAg)
Number of subjects: 538
Study: 18940221

Group type: EXPERIMENTAL
Intervention: Encepur Children
Number of subjects: 334

Group type: COMPARATOR
Intervention: FSME‐IMMUN Junior
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Encepur Children (third dose)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 334
Study: 17075252

Group type: EXPERIMENTAL
Intervention: 0.025% levocabastine hydrochloride ophthalmic suspension
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 24
Study: 15452470

Group type: EXPERIMENTAL
Intervention: Adult TEE probe
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pediatric TEE probe
Number of subjects: 20
Study: 11525550

Group type: EXPERIMENTAL
Intervention: Clinician assessment of habitual contact lens fluorescein patterns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photograph readers' assessment of habitual contact lens fluorescein patterns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photograph readers' re-reads of fluorescein pattern slides
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinician assessment of habitual fit fluorescein patterns
Number of subjects: 0
Study: 10188418

Group type: EXPERIMENTAL
Intervention: Snoezelen sensory environment intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pain management programme (multidisciplinary approach)
Number of subjects: 0
Study: 7918818

Group type: EXPERIMENTAL
Intervention: Telephone survey (response rate 49%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Household survey (response rate 77%)
Number of subjects: 0
Study: 2454372

Group type: EXPERIMENTAL
Intervention: Carvedilol (12.5 to 200 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol (40 to 320 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pindolol (2.5 to 20 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Labetalol (50 to 400 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31924530

Group type: EXPERIMENTAL
Intervention: Scleral rigid gas permeable contact lenses (SL)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Corneal rigid gas permeable contact lenses (CoL)
Number of subjects: 34
Study: 29423840

Group type: EXPERIMENTAL
Intervention: LED therapy (λ627 ± 10 nm) with an energy density of 10 J/cm2 for 6 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo therapy (LED therapy turned off) for 6 days
Number of subjects: 40
Study: 26727411

Group type: EXPERIMENTAL
Intervention: Cognitive debiasing intervention (education on cognitive pitfalls and corrective strategies)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Brief overview of PBD (control condition)
Number of subjects: 137
Study: 24865166

Group type: EXPERIMENTAL
Intervention: Active for Life Year 5 (AFLY5) intervention
Number of subjects: 2221

Group type: COMPARATOR
Intervention: Control group (standard teaching)
Number of subjects: 2221
Study: 23225211

Group type: EXPERIMENTAL
Intervention: Lycopene-enriched virgin olive oil (7 mg lycopene day(‐1))
Number of subjects: 3

Group type: COMPARATOR
Intervention: Virgin olive oil
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sunflower oil
Number of subjects: 3
Study: 21519311

Group type: EXPERIMENTAL
Intervention: Catheter insertion 0 to 1 cm past the needle tip
Number of subjects: 100

Group type: COMPARATOR
Intervention: Catheter insertion 5 to 6 cm past the needle tip
Number of subjects: 100
Study: 18274695

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.1 mg/d)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 16509174

Group type: EXPERIMENTAL
Intervention: Self-management education programme 'Airways'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 15080229

Group type: EXPERIMENTAL
Intervention: Functional Electrical Therapy (FET)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control
Number of subjects: 28
Study: 10759052

Group type: EXPERIMENTAL
Intervention: Operational Stress Training Package
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Psychological Debriefing (PD)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no PD)
Number of subjects: 106
Study: 8847329

Group type: EXPERIMENTAL
Intervention: Fluid ingestion (FR)
Number of subjects: 5
Study: 1403589

Group type: EXPERIMENTAL
Intervention: Antiseptic mouthwash
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control rinse
Number of subjects: 18
Study: 3602014

Group type: EXPERIMENTAL
Intervention: Pentoxifylline ('Trental' 400) 400 mg 3-times daily for two 3-month periods interrupted by a 4-week wash-out period
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29032853

Group type: EXPERIMENTAL
Intervention: Antioxidants and zinc supplementation
Number of subjects: 879

Group type: COMPARATOR
Intervention: Genotype claims
Number of subjects: 879
Study: 26450456

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 40
Study: 24851237

Group type: EXPERIMENTAL
Intervention: BoNTA (10 U)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study: 22944392

Group type: EXPERIMENTAL
Intervention: Immediate passive motion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Strict immobilization
Number of subjects: 100
Study: 20691129

Group type: EXPERIMENTAL
Intervention: CHO-enriched meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Monounsaturated fat-enriched meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saturated fat-enriched meal
Number of subjects: 20
Study: 18313028

Group type: EXPERIMENTAL
Intervention: Glutamate injection into the masseter muscle
Number of subjects: 57
Study: 19422443

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard treatment alone (Control)
Number of subjects: 103
Study: 15002073

Group type: EXPERIMENTAL
Intervention: Normothermia (37 degrees C)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Hypothermia (32 degrees C)
Number of subjects: 48
Study: 11725598

Group type: EXPERIMENTAL
Intervention: Shuttle walking test with fitness training
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Shuttle walking test with various orthopaedic treatments
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Shuttle walking test reliability
Number of subjects: 44
Study: 9012640

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg/d)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control subjects (normolipidemic)
Number of subjects: 5
Study: 8189562

Group type: EXPERIMENTAL
Intervention: Duplex ultrasound (10 MHz color Doppler unit after intracorporeal pharmacological stimulation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nocturnal penile tumescence evaluation (measured at a sleep laboratory)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Duplex ultrasound
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nocturnal penile tumescence
Number of subjects: 40
Study: 3099102

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin 2 (rIL2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Phytohemagglutinin
Number of subjects: 10
Study: 31634194

Group type: EXPERIMENTAL
Intervention: Immediate ART (EAAA)
Number of subjects: 2629

Group type: COMPARATOR
Intervention: Control (delayed ART)
Number of subjects: 2629
Study: 31117853

Group type: EXPERIMENTAL
Intervention: Atrial anti-tachycardia pacing (A‐ATP) from a Medtronic dual‐chamber pacemaker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atrial anti-tachycardia pacing (A‐ATP)
Number of subjects: 0
Study: 28156130

Group type: EXPERIMENTAL
Intervention: ThermoSuit (TS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: EMCOOLS Flex.Pad (EC)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Body-cooling unit (BCU)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No cooling (CON)
Number of subjects: 22
Study: 25311594

Group type: EXPERIMENTAL
Intervention: Intensive voice therapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional voice therapy
Number of subjects: 53
Study: 23657728

Group type: EXPERIMENTAL
Intervention: NT-proBNP-guided management
Number of subjects: 123

Group type: COMPARATOR
Intervention: Symptom-guided management
Number of subjects: 123
Study: 21384174

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 1158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1158
Study: 19117884

Group type: EXPERIMENTAL
Intervention: Restrictive hemoglobin transfusion threshold
Number of subjects: 451

Group type: COMPARATOR
Intervention: Liberal hemoglobin transfusion threshold
Number of subjects: 451
Study: 17088509

Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 0
Study: 14702268

Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study: 11758004

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae infection (measured by IgG and IgA antibodies) in CAD patients with CRF
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae infection (measured by IgG and IgA antibodies) in all CAD patients
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Mean antibody index of IgG in CAD patients
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Levels of IgG in CAD patients
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: IgA levels in CAD patients with CRF
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Elevated IgG antibody index
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Elevated IgA index
Number of subjects: 214
Study: 9158267

Group type: EXPERIMENTAL
Intervention: Lyrelle 50
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Lyrelle 80
Number of subjects: 394

Group type: COMPARATOR
Intervention: Estraderm TTS 50
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: All groups (Lyrelle 50, Lyrelle 80, Estraderm TTS 50)
Number of subjects: 394
Study: 7951567

Group type: EXPERIMENTAL
Intervention: Euglycemic insulin clamp technique achieving hyperinsulinemia (50‐70 microU/ml) in NGT subjects (n = 13)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Euglycemic insulin clamp technique achieving hyperinsulinemia (50‐70 microU/ml) in BGI subjects (n = 12)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Euglycemic insulin clamp technique achieving hyperinsulinemia (50‐70 microU/ml) in NIDDM subjects (n = 12)
Number of subjects: 37
Study: 3661614

Group type: EXPERIMENTAL
Intervention: Sucralfate 1 g twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29511780

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 18
Study: 26604097

Group type: EXPERIMENTAL
Intervention: Placebo educational intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control education
Number of subjects: 0
Study: 25500097

Group type: EXPERIMENTAL
Intervention: Interactive Preventive Health Record (IPHR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional Personal Health Records (PHRs)
Number of subjects: 40
Study: 22850577

Group type: EXPERIMENTAL
Intervention: Triaxial system
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional system (control group)
Number of subjects: 63
Study: 20335136

Group type: EXPERIMENTAL
Intervention: Organized stroke ward
Number of subjects: 2637

Group type: COMPARATOR
Intervention: General ward
Number of subjects: 2637
Study: 18725822

Group type: EXPERIMENTAL
Intervention: Provider intervention featuring academic detailing and strategic planning session
Number of subjects: 2224

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2224

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 2224
Study: 15982990

Group type: EXPERIMENTAL
Intervention: 200mg G115
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 400mg G115
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12074223

Group type: EXPERIMENTAL
Intervention: Slow flow rate (161 sec/mL) of 0.3 mL local anesthetic solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fast flow rate (29 sec/mL) of 0.3 mL local anesthetic solution
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heart rate as a physiologic indicator of pain response
Number of subjects: 20
Study: 9605697

Group type: EXPERIMENTAL
Intervention: Forced-air warming (FAW)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine thermal care
Number of subjects: 100
Study: 8083715

Group type: EXPERIMENTAL
Intervention: Front-loading consolidation therapy (6 MTX/Ara-C infusions at 3-week intervals from 7th to 19th week)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Standard consolidation therapy (6 MTX/Ara-C infusions every 12 weeks from 7th to 67th week)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Front-loading regimen
Number of subjects: 428

Group type: COMPARATOR
Intervention: Standard regimen
Number of subjects: 428
Study: 2671408

Group type: EXPERIMENTAL
Intervention: Well matched cadaver renal allografts shared among transplantation centers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Organs of local origin matched only for blood group
Number of subjects: 0
Study: 146411

Group type: EXPERIMENTAL
Intervention: Parachlorophenylalanine and testosterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parachlorophenylalanine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Testosterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tryptophan
Number of subjects: 0
Study: 30383672

Group type: EXPERIMENTAL
Intervention: Imaginary Working Qigong training for 8 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Unaltered lifestyle control group
Number of subjects: 80
Study: 27381831

Group type: EXPERIMENTAL
Intervention: Neoadjuvant Capecitabine and Oxaliplatin (CAPOX)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Neoadjuvant Capecitabine and Oxaliplatin (CAPOX) + Cetuximab (CAPOX-C)
Number of subjects: 155
Study: 24724577

Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correction for coagulation factors
Number of subjects: 0
Study: 22304627

Group type: EXPERIMENTAL
Intervention: 250 μg of r-hCG
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 500 μg of r-hCG
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 118
Study: 19604542

Group type: COMPARATOR
Intervention: 75 mg/day clopidogrel
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 150 mg/day clopidogrel
Number of subjects: 54
Study: 18756184

Group type: EXPERIMENTAL
Intervention: Concomitant use of oral pentavalent rotavirus vaccine (PRV) and oral poliovirus vaccine (OPV)
Number of subjects: 735

Group type: COMPARATOR
Intervention: Staggered use of PRV 2-4 weeks before OPV
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: Concomitant use of PRV and OPV
Number of subjects: 735
Study: 15715552

Group type: EXPERIMENTAL
Intervention: AcrySof MA30BA
Number of subjects: 175

Group type: COMPARATOR
Intervention: Sensar AR40e
Number of subjects: 175

Group type: COMPARATOR
Intervention: AcrySof SA30AL
Number of subjects: 175

Group type: COMPARATOR
Intervention: Tecnis Z9000
Number of subjects: 175

Group type: COMPARATOR
Intervention: Sensar AR40
Number of subjects: 175
Study: 12675275

Group type: EXPERIMENTAL
Intervention: Azelnidipine 16 mg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 46
Study: 11276181

Group type: EXPERIMENTAL
Intervention: Anteroposterior mobilization on the talus in addition to RICE protocol
Number of subjects: 41

Group type: COMPARATOR
Intervention: RICE protocol
Number of subjects: 41
Study: 9097267

Group type: EXPERIMENTAL
Intervention: rIFN-alpha 2b (1.5 MU, increasing to 3 MU if no response)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Identical placebo
Number of subjects: 23
Study: 1371633

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg p.o.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Atropine 0.01 mg/kg i.m.
Number of subjects: 60

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 60
Study: 3873866

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 28735763

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no PRP treatment)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 29332637

Group type: EXPERIMENTAL
Intervention: Disorder-oriented multicomponent group therapy (12 sessions of 90 minutes each) integrating interactive psychoeducation, gut-directed hypnotherapy, and open group phases.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-listed control condition with enhanced medical care and a short online diary.
Number of subjects: 30
Study: 26625419

Group type: EXPERIMENTAL
Intervention: Adaptive Catching
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Free Catching
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Interceptive Catching
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (Mario game)
Number of subjects: 41